Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Jordan Brown - Family’s Support Spurs Recovery

    ... care in Virginia to have the cysts lanced and was given a blood test during the procedure. On Monday July 14th, I received a call at ... back in the normal range, he had taken off his mask and his red count was approaching normal. Jordan decided to go on with life.  He could ...

    Patient Chronicle last updated 10/12/2015 - 8:11am.

  2. Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

    Journal Title:  Blood Primary Author:  Peffault ... During the study, six patients received at least one red blood cell transfusion . Lack of detectable CH50 activity (defined by ...

    Research Article last updated 01/20/2015 - 2:28pm.

  3. AAMDSIF Liviya Anderson Research Fund

    ... age of six, Liviya was taken to the emergency room after her blood work came back from the pediatrician with dangerously low blood counts. ... platelet transfusions immediately. Liviya’s red blood cell count was so low that her body wasn’t getting the oxygen ...

    Research Fund last updated 06/08/2017 - 3:49pm.

  4. The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes

    ... patients with MDS conducted Cox regression analyses of red blood cell or platelet dependence, myelosuppression, dose ...

    Research Article last updated 06/02/2014 - 11:03am.

  5. Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

    Journal Title:  Blood Primary Author:  Itzykson ... cytogenetics , presence of circulating blasts, and red blood cell transfusion dependency ≥ 4 units/8 weeks (all P < 10(-4)) ...

    Research Article last updated 07/28/2014 - 8:53am.

  6. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

    ... to Medicare claims. Baseline characteristics, treatment ( red blood cell transfusions, hematopoietic growth factors, hypomethylating ...

    Research Article last updated 11/19/2012 - 2:37pm.

  7. A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data

    ... marker. METHODS: We analyzed 979 complete blood counts (CBC) data from 963 patients including 57 data from 44 PNH ... were followed: flow cytometry for CD55 and CD59 on red blood cells (RBCs) to a detection level of 1%; and fluorescent aerolysin, ...

    Research Article last updated 03/02/2015 - 11:39am.

  8. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline.

    ... expected with the aging population. Treatment includes red blood cell transfusion for anemia . The immunomodulatory agents ...

    Research Article last updated 10/01/2012 - 10:04am.

  9. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

    ... risks associated with transfusions, chronic anemia and red blood cell (RBC) transfusion dependence impact negatively on survival and ...

    Research Article last updated 06/15/2012 - 2:03pm.

  10. Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.

    ... 24 and 52 weeks of therapy despite ongoing receipt of red blood cell transfusions. Bone Marrow ...

    Research Article last updated 10/11/2011 - 5:58pm.